EURION, European Cluster to Improve Identification of Endocrine Disruptors, kindly asks for your input to an initial general survey of stakeholders’ interests, needs and priorities in relation to the development of endocrine disruptor (ED) test methods: participate in the survey.
EURION (www.eurion-cluster.eu) is a cluster of eight European research projects, funded by the European Union’s Horizon 2020 research and innovation programme. The projects are focusing on the development of new ED test methods targeting relevant endpoints that are not sufficiently covered by current regulatory tests.
As a stakeholder of EURION, you are invited to contribute your opinion on what criteria should be considered the most important for the development of these test methods. Your contribution will be critical to inform EURION, and ultimately to the development of new tests that are urgently needed for hazard assessment of EDs. The results of this survey will be presented and discussed at an EURION Stakeholder Workshop planned to take place on 19 October 2020, more details will be confirmed soon.
Please note all data provided in the survey will be handled in accordance with the General Data Protection Regulation (EU 2016/679) (“GDPR”). The results of the survey will be presented anonymously. By participating in and submitting this survey, participants confirm they have read this information and agree that the information provided within the survey may be used for EURION purposes, including presentations and exchange among relevant stakeholders as well as potential related materials, published papers and reports.
EURION Stakeholder Survey on Endocrine Disruptor Test Methods is a short (5-10 mins) survey open for contributions until 11 September 2020: PARTICIPATE IN THE SURVEY
For more information contact the ENDpoiNTs and ERGO Coordination 2020-2021 Team:
Joëlle Rüegg (ENDpoiNTS)
Henrik Holbech (ERGO)
EURION Communication and Press:
Avril Hanbidge (ERGO)